Role of natural killer cells in Pichinde virus infection of Syrian hamsters.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 351406)

Published in Infect Immun on March 01, 1981

Authors

S R Gee, M A Chan, D A Clark, W E Rawls

Articles cited by this

Separation of cells by velocity sedimentation. J Cell Physiol (1969) 8.73

Secretory immunoglobulins. Adv Immunol (1968) 7.00

Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00

Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells. J Immunol (1978) 2.04

The reticuloendothelium as the target in a virus infection. Pichinde virus pathogenesis in two strains of hamsters. Lab Invest (1977) 1.41

THE PATHOGENESIS OF LYMPHOCYTIC CHORIOMENINGITIS IN MICE: THE EFFECTS OF DIFFERENT INOCULATION ROUTES AND THE FOOTPAD RESPONSE. J Immunol (1963) 1.39

Cell-mediated immune response to lymphocytic choriomeningitis and vaccinia virus in rats. J Immunol (1977) 1.31

Variation between strains of hamsters in the lethality of Pichinde virus infections. Infect Immun (1977) 1.28

The immune response to influenza virus. I. Effect of the route and schedule of vaccination on the time course of the immune response, as measured by three serological methods. Immunology (1965) 1.21

The immune response to influenza virus. II. Effect of the route and schedule of vaccination on the quantity and avidity of antibodies. Immunology (1968) 1.09

Differences between Syrian hamster strains in natural killer cell activity induced by infection with Pichinde virus. J Immunol (1979) 1.04

Serological evidence of infection by Pichinde virus among laboratory workers. Infect Immun (1974) 0.92

Articles by these authors

(truncated to the top 100)

Biological markers for differentiation of herpes-virus strains of oral and genital origin. J Gen Virol (1969) 3.32

Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol (1968) 3.29

Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. Proc Natl Acad Sci U S A (1980) 3.18

Herpesvirus type 2: association with carcinoma of the cervix. Science (1968) 3.03

Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun (1982) 3.02

Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A (1980) 2.94

A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties. Am J Epidemiol (1968) 2.92

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. J Clin Oncol (1988) 2.91

The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol (1969) 2.74

Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem (1998) 2.66

Appraising Public Medical Services. Am J Public Health Nations Health (1941) 2.62

An information processing model of anxiety: automatic and strategic processes. Behav Res Ther (1997) 2.55

Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther (1993) 2.54

Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity. Biochem Biophys Res Commun (1980) 2.49

Measurement of antibodies to herpesvirus types 1 and 2 in human sera. J Immunol (1970) 2.45

The cardiac donor. Surg Gynecol Obstet (1971) 2.39

Infectious complications after cardiac transplantation in man. Ann Intern Med (1971) 2.37

Structure of leukotriene C. Identification of the amino acid part. Biochem Biophys Res Commun (1979) 2.30

Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies. J Virol (1982) 2.24

WHO collaborative study on the sero-epidemiology of rubella. Bull World Health Organ (1967) 2.17

Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J Exp Med (1982) 2.12

American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2001) 2.09

Selective assay for herpes simplex viruses expressing thymidine kinase. J Virol (1979) 2.03

Longitudinal study of serum lipids. 12-year report. Am J Clin Nutr (1967) 2.00

Viral inhibition of the phytohemagglutinin response of human lymphocytes and application to viral hepatitis. Proc Soc Exp Biol Med (1969) 2.00

Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Cathet Cardiovasc Diagn (1991) 2.00

Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med (1989) 1.94

Monoclonal antibodies to two glycoproteins of herpes simplex virus type 2. J Virol (1981) 1.94

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology (2009) 1.93

The IgM antibody response in rubella during pregnancy. J Med Microbiol (1971) 1.85

Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med (1968) 1.82

Evidence for a common mucosal immunologic system. II. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J Immunol (1980) 1.79

Antigenic differences between isolates of herpesvirus type 2. Intervirology (1974) 1.79

Replication of poliovirus in phytohemagglutinin-stimulated human lymphocytes. J Virol (1969) 1.70

Identification and typing of herpes simplex viruses with monoclonal antibodies. J Clin Microbiol (1982) 1.68

Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2. J Immunol (1972) 1.68

Leukotriene A: stereochemistry and enzymatic conversion to leukotriene B. Biochem Biophys Res Commun (1980) 1.62

Serologic diagnosis and fetal involvement in maternal rubella. Criteria for abortion. JAMA (1968) 1.61

An in vitro measure of cellular immunity to fibroma virus. J Immunol (1970) 1.58

Improved rapidity and precision in the determination of brain 2',3'-cyclic nucleotide 3'-phosphohydrolase. Anal Biochem (1973) 1.55

Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol (1994) 1.55

Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter. Am J Epidemiol (1967) 1.55

Control of fetal survival in CBA x DBA/2 mice by lymphokine therapy. J Reprod Fertil (1990) 1.54

Rubella virus neutralization by plaque reduction. Proc Soc Exp Biol Med (1967) 1.53

A human interferon that crosses the species line. Proc Natl Acad Sci U S A (1968) 1.52

Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin's disease: results of a case-control study. Eur J Cancer (1995) 1.52

Characteristics of Sulfobacillus acidophilus sp. nov. and other moderately thermophilic mineral-sulphide-oxidizing bacteria. Microbiology (1996) 1.50

A morphological and immunological study of human placental bed biopsies in miscarriage. Br J Obstet Gynaecol (1990) 1.49

Murine intestinal intraepithelial lymphocytes I. Relationship of a novel Thy-1-,Lyt-1-,Lyt-2+, granulated subpopulation to natural killer cells and mast cells. Eur J Immunol (1985) 1.49

Characterization of nucleic acid of pichinde virus. J Virol (1973) 1.48

Hemodynamic performance of the transplanted human heart. Surgery (1971) 1.47

Encephalitis associated with herpes simplex virus. Ann Intern Med (1966) 1.46

In vitro assessment of cellular immunity to vaccinia virus: contribution of lymphocytes and macrophages. Infect Immun (1970) 1.46

Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis. Proc Natl Acad Sci U S A (1981) 1.45

Rubella virus carrier cultures derived from congenitally infected infants. J Exp Med (1966) 1.45

Sexual and socioeconomic factors affecting the risk of past infections with herpes simplex virus type 2. Am J Epidemiol (1983) 1.45

Isolation and characterization of an aetiological agent in Whipple's disease. Br Med J (1975) 1.43

Provocation of coronary spasm with ergonovine maleate. New test with results in 57 patients undergoing coronary arteriography. Am J Cardiol (1977) 1.42

The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer (1989) 1.42

Antibodies to viral antigens in systemic lupus erythematosus. Arthritis Rheum (1971) 1.42

Investigation of plaque formation in chick embryo cells as a biological marker for distinguishing herpes virus type 2 from type 1. J Gen Virol (1971) 1.42

Laparoscopic resection of advanced colorectal cancer. Br J Surg (2010) 1.41

Red-cell antibodies in pregnancy: evidence overturned. Lancet (1996) 1.41

The reticuloendothelium as the target in a virus infection. Pichinde virus pathogenesis in two strains of hamsters. Lab Invest (1977) 1.41

Arrival of femoral closure devices and the demise of brachial angiography and interventions. Cathet Cardiovasc Diagn (1997) 1.40

Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of Herpes simplex virus types 1 and 2. Am J Epidemiol (1976) 1.40

The ideal ileal-pouch design: a long-term randomized control trial of J- vs W-pouch construction. Dis Colon Rectum (2012) 1.39

Controversies in diagnosis and management of recurrent spontaneous abortion. Am J Reprod Immunol (1997) 1.39

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med (1987) 1.38

Viral inhibition of lymphocyte response to phytohemagglutinin. Science (1967) 1.37

Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population. Cancer (1990) 1.37

Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis (1993) 1.36

Herpesvirus-type-2 antibodies and carcinoma of the cervix. Lancet (1970) 1.35

The kidneys in paroxysmal nocturnal hemoglobinuria. Blood (1981) 1.34

Coronary artery spasm. medical management, surgical denervation, and autotransplantation. J Thorac Cardiovasc Surg (1977) 1.33

Parity as a risk factor for cervical cancer. Am J Epidemiol (1989) 1.33

Structural proteins of Pichinde virus. J Virol (1972) 1.33

Congenital rubella: the significance of virus persistence. Prog Med Virol (1968) 1.33

Herpes genitalis treated by photodynamic inactivation of virus. Am J Obstet Gynecol (1973) 1.32

Effects of actinomycin D and ultraviolet and ionizing radiation on Pichinde virus. J Virol (1973) 1.31

Impairment of host vs graft reaction in pregnant mice. I. Suppression of cytotoxic T cell generation in lymph nodes draining the uterus. J Immunol (1978) 1.31

Antibodies to surface antigens of herpesvirus type 1- and type 2-infected cells among women with cervical cancer and control women. Infect Immun (1972) 1.30

Cardiac transplantation in man. Review of first three years' experience. Am J Med (1973) 1.30

Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology (1991) 1.30

Analysis of a measles epidemic; possible role of vaccine failures. Can Med Assoc J (1975) 1.29

Variation between strains of hamsters in the lethality of Pichinde virus infections. Infect Immun (1977) 1.28

The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol (1992) 1.27

Anemia of prematurity: determinants of the erythropoietin response. J Pediatr (1984) 1.27

Direct immunofluorescence test for the diagnosis of genital herpesvirus infections. Appl Microbiol (1973) 1.27

Betaherpesviruses in transplant recipients. J Antimicrob Chemother (2000) 1.26

Interferon in congenital rubella: response to live attenuated measles vaccine. J Immunol (1967) 1.26

Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine. Gut (2002) 1.25

Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav Res Ther (1999) 1.25

Clinical features of herpes genitalis. Cancer Res (1973) 1.24

Congenital malformation of the central nervous system associated with genital type (type 2) herpesvirus. J Pediatr (1969) 1.24

Genital herpes in two social groups. Am J Obstet Gynecol (1971) 1.24

Production of hybrid cell lines secreting antibodies to herpes simplex virus type 2. J Virol Methods (1981) 1.22

Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest (1992) 1.21

Quantitation of antibodies to Herpes simplex virus types 1 and 2 by complement-dependent antibody lysis of infected cells. Am J Epidemiol (1976) 1.20

Virion-associated ribosomes are not required for the replication of Pichinde virus. Virology (1977) 1.20